figshareBrowse
Table 3.xls (5.5 kB)
Download file

A propensity score for receiving carbapenem adjusted, multivariable analysis of 30-day acquisition of multi-drug resistant bacterial and fungal infections for 151 patients with ESBL-producing E. coli and K. pneumoniae bacteraemia, receiving either empiric piperacllin-tazobactam or carbapenem.

Download (5.5 kB)
dataset
posted on 22.04.2016, 06:20 by Tat Ming Ng, Wendy X. Khong, Patrick N. A. Harris, Partha P. De, Angela Chow, Paul A. Tambyah, David C. Lye

A propensity score for receiving carbapenem adjusted, multivariable analysis of 30-day acquisition of multi-drug resistant bacterial and fungal infections for 151 patients with ESBL-producing E. coli and K. pneumoniae bacteraemia, receiving either empiric piperacllin-tazobactam or carbapenem.

History

Usage metrics

Read the peer-reviewed publication

Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae
PLOS ONEPLOS ONE

Categories

Keywords

propensity scoreempiric monotherapyrisk factorsmortalityLimited dataempiric carbapenem therapymultivariate analysisCIESBLKlebsiella pneumoniae bacteraemia394 patients

Licence

CC BY 4.0

Exports